DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cymbalta (Duloxetine) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (165)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cymbalta (Duloxetine) life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 165   Next >>

Possible Cymbalta side effects in female

Reported by a physician from France on 2012-08-27

Patient: female

Reactions: Confusional State, Acute Pulmonary Oedema, Agitation, Renal Failure Acute

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Acetaminophen
    Administration route: Oral
    End date: 2012-07-26

Aspirin
    Administration route: Oral

Atorvastatin
    Administration route: Oral

Bisoprolol Fumarate
    Dosage: 2.5 mg in the morning and 1.25 mg in the evening
    Administration route: Oral
    End date: 2012-07-27

Cymbalta
    Administration route: Oral
    End date: 2012-07-26

Duragesic-100
    End date: 2012-07-26

Lercanidipine
    Administration route: Oral
    End date: 2012-07-26

Lyrica
    Administration route: Oral
    End date: 2012-07-26

Nexium
    Administration route: Oral

Nitroglycerin
    End date: 2012-07-26

Plavix
    Administration route: Oral

Ramipril
    Administration route: Oral
    End date: 2012-07-26

Zometa
    Start date: 2012-07-19
    End date: 2012-07-19



Possible Cymbalta side effects in 61 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-27

Patient: 61 year old female

Reactions: Agitation, Confusional State, Acute Pulmonary Oedema, Metastatic Pain, Hypercalcaemia, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Dosage: 1 g, 1x/day
    Administration route: Oral
    End date: 2012-07-26

Aspirin
    Dosage: 75 mg, 1x/day
    Administration route: Oral

Atorvastatin
    Dosage: 10 mg, 1x/day
    Administration route: Oral

Bisoprolol Fumarate
    Dosage: 3.75 mg, 1x/day
    Administration route: Oral
    End date: 2012-07-27

Cymbalta
    Dosage: 60 mg, 1x/day
    Administration route: Oral
    End date: 2012-07-26

Duragesic-100
    Dosage: 50 mg, 1x/day
    End date: 2012-07-26

Lercanidipine
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    End date: 2012-07-26

Lyrica
    Dosage: 75 mg, 2x/day
    Administration route: Oral
    End date: 2012-07-26

Nexium
    Dosage: 20 mg, 1x/day
    Administration route: Oral

Nitroglycerin
    Dosage: 5 mg, 1x/day
    End date: 2012-07-26

Plavix
    Dosage: 75 mg, 1x/day
    Administration route: Oral

Ramipril
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    End date: 2012-07-26

Zometa
    Dosage: 4 mg, single
    Indication: Hypercalcaemia
    Start date: 2012-07-19
    End date: 2012-07-19



Possible Cymbalta side effects in 61 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-27

Patient: 61 year old female

Reactions: Confusional State, Agitation, Renal Failure Acute

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Acetaminophen
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-07-26

Aspirin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Atorvastatin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Bisoprolol Fumarate
    Dosage: 2.5-0-1.25
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-07-27

Cymbalta
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-07-26

Duragesic-100
    Indication: Product Used FOR Unknown Indication
    End date: 2012-07-26

Lercanidipine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-07-26

Lyrica
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-07-26

Nexium
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Nitroglycerin
    Indication: Product Used FOR Unknown Indication
    End date: 2012-07-27

Plavix
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Ramipril
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2012-07-26

Zometa
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-19
    End date: 2012-07-19



Possible Cymbalta side effects in 46 year old female

Reported by a physician from Australia on 2012-08-24

Patient: 46 year old female

Reactions: Off Label Use, Electrocardiogram QT Prolonged, Ventricular Fibrillation

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Cymbalta
    Administration route: Oral

Seroquel
    Administration route: Oral

Other drugs received by patient: Opiates; Reboxetine



Possible Cymbalta side effects in female

Reported by a physician from France on 2012-08-24

Patient: female

Reactions: Confusional State, Nephrolithiasis, Acute Pulmonary Oedema, Agitation, Dyspnoea, Hypercalcaemia, Renal Failure Acute

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Acetaminophen
    Dosage: 1 mg, unk
    End date: 2012-07-26

Aspirin
    Dosage: 75 mg, unk

Atorvastatin
    Dosage: 10 mg, qd

Bisoprolol Fumarate
    Dosage: 3.75 mg, daily (2.5 mg in the morning and 1.25 mg in the evening)
    End date: 2012-07-27

Cymbalta
    Dosage: 60 mg, qd
    End date: 2012-07-26

Duragesic-100
    Dosage: 50 ug, daily
    End date: 2012-07-26

Lercanidipine
    Dosage: 10 mg, qd
    End date: 2012-07-26

Lyrica
    Dosage: 75 mg, bid
    End date: 2012-07-26

Nexium
    Dosage: 20 mg, qd
    End date: 2012-07-26

Nitroglycerin
    Dosage: 5 mg, daily
    End date: 2012-07-27

Plavix
    Dosage: 75 mg, qd
    End date: 2012-07-26

Ramipril
    Dosage: 10 mg, qd
    End date: 2012-07-26

Zometa
    Dosage: 4 mg, in 15 min
    Indication: Hypercalcaemia
    Start date: 2012-07-19



Possible Cymbalta side effects in female

Reported by a physician from France on 2012-08-24

Patient: female

Reactions: Agitation, Confusional State, Acute Pulmonary Oedema, Nephrolithiasis, Dyspnoea, Hypercalcaemia, Renal Failure Acute

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Acetaminophen
    Dosage: 1 mg, unk
    End date: 2012-07-26

Aspirin
    Dosage: 75 mg, unk

Atorvastatin
    Dosage: 10 mg, qd

Bisoprolol Fumarate
    Dosage: 3.75 mg, daily (2.5 mg in the morning and 1.25 mg in the evening)
    End date: 2012-07-27

Cymbalta
    Dosage: 60 mg, qd
    End date: 2012-07-26

Duragesic-100
    Dosage: 50 ug, daily
    End date: 2012-07-26

Lercanidipine
    Dosage: 10 mg, qd
    End date: 2012-07-26

Lyrica
    Dosage: 75 mg, bid
    End date: 2012-07-26

Nexium
    Dosage: 20 mg, qd
    End date: 2012-07-26

Nitroglycerin
    Dosage: 5 mg, daily
    End date: 2012-07-27

Plavix
    Dosage: 75 mg, qd
    End date: 2012-07-26

Ramipril
    Dosage: 10 mg, qd
    End date: 2012-07-26

Zometa
    Dosage: 4 mg, in 15 min
    Indication: Hypercalcaemia
    Start date: 2012-07-19



Possible Cymbalta side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-24

Patient: female

Reactions: Agitation, Confusional State, Renal Failure Acute

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Acetaminophen
    Administration route: Oral
    End date: 2012-07-26

Aspirin
    Administration route: Oral

Atorvastatin
    Administration route: Oral

Bisoprolol Fumarate
    Administration route: Oral
    End date: 2012-07-27

Cymbalta
    Administration route: Oral
    End date: 2012-07-26

Duragesic-100
    End date: 2012-07-26

Lercanidipine
    Administration route: Oral
    End date: 2012-07-26

Lyrica
    Administration route: Oral
    End date: 2012-07-26

Nexium
    Administration route: Oral

Nitroglycerin
    End date: 2012-07-27

Plavix
    Administration route: Oral

Ramipril
    Administration route: Oral
    End date: 2012-07-26

Zometa
    Start date: 2012-07-19
    End date: 2012-07-19



Possible Cymbalta side effects in female

Reported by a physician from France on 2012-08-24

Patient: female

Reactions: Nephrolithiasis, Agitation, Confusional State, Acute Pulmonary Oedema, Dyspnoea, Hypercalcaemia, Renal Failure Acute

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Acetaminophen
    Dosage: 1 mg, unk
    End date: 2012-07-26

Aspirin
    Dosage: 75 mg, unk

Atorvastatin
    Dosage: 10 mg, qd

Bisoprolol Fumarate
    Dosage: 3.75 mg, daily (2.5 mg in the morning and 1.25 mg in the evening)
    End date: 2012-07-27

Cymbalta
    Dosage: 60 mg, qd
    End date: 2012-07-26

Duragesic-100
    Dosage: 50 ug, daily
    End date: 2012-07-26

Lercanidipine
    Dosage: 10 mg, qd
    End date: 2012-07-26

Lyrica
    Dosage: 75 mg, bid
    End date: 2012-07-26

Nexium
    Dosage: 20 mg, qd
    End date: 2012-07-26

Nitroglycerin
    Dosage: 5 mg, daily
    End date: 2012-07-27

Plavix
    Dosage: 75 mg, qd
    End date: 2012-07-26

Ramipril
    Dosage: 10 mg, qd
    End date: 2012-07-26

Zometa
    Dosage: 4 mg, in 15 min
    Indication: Hypercalcaemia
    Start date: 2012-07-19



Possible Cymbalta side effects in female

Reported by a physician from Canada on 2012-08-23

Patient: female, weighing 79.4 kg (174.7 pounds)

Reactions: Sick Sinus Syndrome, Device Related Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: code not broken
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-24
    End date: 2012-07-11

Afinitor
    Dosage: code not broken
    Administration route: Oral
    Start date: 2012-07-19
    End date: 2012-08-01

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Start date: 2012-07-19
    End date: 2012-08-01

Blinded NO Treatment Received
    Dosage: code not broken
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-24
    End date: 2012-07-11

Carbamazepine
    Dosage: 200 mg, tid
    Indication: Convulsion
    Start date: 2001-01-01

Cymbalta
    Dosage: unk
    Indication: Depression
    Start date: 2012-02-10

Insulin
    Dosage: 20 uam 4 upm
    Indication: Diabetes Mellitus
    Start date: 2006-10-01

Levothyroxine Sodium
    Dosage: 150 mg qpm
    Indication: Hypothyroidism
    Start date: 2008-01-01

Lipitor
    Indication: Hypertriglyceridaemia

Lipitor
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Hypercholesterolaemia
    Start date: 2001-01-01

Placebo
    Dosage: code not broken
    Administration route: Oral
    Start date: 2012-07-19
    End date: 2012-08-01

Placebo
    Dosage: code not broken
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-24
    End date: 2012-07-11

Trazodone Hydrochloride
    Dosage: 100 mg, qhs
    Indication: Depression
    Start date: 2008-01-01

Wellbutrin
    Dosage: 150 mg qpm
    Indication: Depression
    Start date: 2008-01-01



Possible Cymbalta side effects in 26 year old female

Reported by a consumer/non-health professional from United Kingdom on 2012-08-23

Patient: 26 year old female

Reactions: Complication of Delivery, Maternal Exposure During Pregnancy, Haemorrhage in Pregnancy

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cymbalta
    Dosage: 120 mg, qd

Cymbalta
    Dosage: 90 mg, unk

Cymbalta
    Dosage: 60 mg, unk
    Indication: Depression



Possible Cymbalta side effects in 28 year old female

Reported by a physician from Switzerland on 2012-08-20

Patient: 28 year old female

Reactions: Maternal Exposure During Pregnancy, Suicide Attempt

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Citalopram Hydrobromide
    Start date: 2007-01-01

Cymbalta
    Start date: 2007-01-01

Effexor
    Administration route: Oral
    Start date: 2008-01-01
    End date: 2012-01-09

Flurazepam
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-12-31

Lamictal
    End date: 2010-01-01

Oxazepam

Seroquel
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-12-31

Tegretol
    Administration route: Oral
    Start date: 2012-01-01



Possible Cymbalta side effects in male

Reported by a health professional (non-physician/pharmacist) from Australia on 2012-08-20

Patient: male

Reactions: Neonatal Respiratory Distress Syndrome, Yawning, Foetal Exposure During Pregnancy, Drug Withdrawal Syndrome, Somnolence, Syndactyly, Congenital Anomaly, Sneezing, Reflexes Abnormal

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cymbalta

Doxepin HCL

Enoxaparin Sodium

Lantus

Quetiapine



Possible Cymbalta side effects in 53 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14

Patient: 53 year old female, weighing 63.5 kg (139.7 pounds)

Reactions: Blood Pressure Increased, Heart Rate Increased, Headache

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cymbalta



Possible Cymbalta side effects in

Reported by a consumer/non-health professional from United States on 2012-08-13

Patient:

Reactions: Respiratory Disorder Neonatal, Foetal Exposure During Pregnancy, Hydrocephalus

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cymbalta
    Dosage: 60 mg, unk

Cymbalta
    Dosage: 60 mg, unk
    Indication: Depression



Possible Cymbalta side effects in female

Reported by a consumer/non-health professional from Germany on 2012-08-13

Patient: female

Reactions: Confusional State, Fracture, Vertigo, Fall, Delirium, Blood Sodium Decreased

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cymbalta

Other drugs received by patient: Enalapril Maleate; Aspirin; Amlodipine; Bisoprolol Fumarate



Possible Cymbalta side effects in female

Reported by a consumer/non-health professional from France on 2012-08-08

Patient: female

Reactions: Weight Decreased, Diarrhoea Neonatal, Hypoglycaemia Neonatal, Exposure During Breast Feeding, Premature Baby, Foetal Exposure During Pregnancy, Drug Withdrawal Syndrome Neonatal, Blood Lactic Acid Increased, Tremor Neonatal, Feeding Disorder Neonatal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cymbalta
    Dosage: 90 mg, qd

Cymbalta
    Dosage: 60 mg, qd

Cymbalta
    Dosage: 30 mg, qd



Possible Cymbalta side effects in 50 year old male

Reported by a health professional (non-physician/pharmacist) from Denmark on 2012-08-07

Patient: 50 year old male, weighing 81.6 kg (179.5 pounds)

Reactions: Confusional State, Bipolar Disorder, Condition Aggravated, Cardiac Disorder, Aggression

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Cymbalta
    Indication: Major Depression
    Start date: 2010-07-02
    End date: 2010-07-28

Cymbalta
    Start date: 2010-07-29
    End date: 2011-11-06

Escitalopram

Other drugs received by patient: Kemadrin; Teva-Pantoprazole; Zyprexa; Rivotril; Clonazepam; Pantoprazole Sodium; PMS-Procyclidine; Topiramate



Possible Cymbalta side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-06

Patient: female, weighing 79.4 kg (174.7 pounds)

Reactions: Sick Sinus Syndrome, Device Related Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: double blinded
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-24
    End date: 2012-07-11

Afinitor
    Dosage: double blinded
    Administration route: Oral
    End date: 2012-08-01

Blinded NO Treatment Received
    Dosage: double blinded
    Administration route: Oral
    End date: 2012-08-01

Blinded NO Treatment Received
    Dosage: double blinded
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-24
    End date: 2012-07-11

Carbamazepine
    Dosage: 200 mg, tid
    Indication: Convulsion
    Start date: 2001-01-01

Cymbalta
    Dosage: unk
    Indication: Depression
    Start date: 2012-02-10

Insulin
    Dosage: 20 uam 4 upm
    Indication: Diabetes Mellitus
    Start date: 2006-10-01

Levothyroxine Sodium
    Dosage: 150 mg qpm
    Indication: Hypothyroidism
    Start date: 2008-01-01

Lipitor
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Hypercholesterolaemia
    Start date: 2001-01-01

Lipitor
    Indication: Hypertriglyceridaemia

Placebo
    Dosage: double blinded
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-24
    End date: 2012-07-11

Placebo
    Dosage: double blinded
    Administration route: Oral
    End date: 2012-08-01

Trazodone Hydrochloride
    Dosage: 100 mg, qhs
    Indication: Depression
    Start date: 2008-01-01

Wellbutrin
    Dosage: 150 mg qpm
    Indication: Depression
    Start date: 2008-01-01



Possible Cymbalta side effects in male

Reported by a physician from Japan on 2012-08-06

Patient: male

Reactions: Off Label Use, Pneumonia Aspiration, Somnolence

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Cymbalta

Other drugs received by patient: Lansoprazole; Voltaren; Oxycontin; Etodolac; Oxycontin; Magmitt; Zometa; Oxycontin; Oxinorm / 00045603 /; Oxinorm / 00045603 /; Lasix; Oxycontin; Flomox; Voltaren; Lyrica



Possible Cymbalta side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient: female, weighing 61.7 kg (135.7 pounds)

Reactions: Vomiting, Head Injury, Subarachnoid Haemorrhage, Headache, Stress

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cymbalta
    Dosage: 60 mg capsule 1/day po approximately 2.5 months
    Administration route: Oral
    Indication: Depression

Generic Excedrin Acet 250mg, Aspirin 250mg. CVS
    Dosage: 1-2 tablet when needed po approximately 2 months
    Administration route: Oral
    Indication: Headache

Other drugs received by patient: Estrotest



Possible Cymbalta side effects in male

Reported by a physician from Japan on 2012-07-25

Patient: male, weighing 67.0 kg (147.4 pounds)

Reactions: Hypoglycaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cymbalta

Other drugs received by patient: Actos; Basen; Avapro; Sitagliptin Phosphate; Neurotropin / 06251301 /; Amaryl; Sitagliptin Phosphate; Basen



Possible Cymbalta side effects in male

Reported by a consumer/non-health professional from Germany on 2012-07-23

Patient: male

Reactions: Pulmonary Embolism

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cymbalta



Possible Cymbalta side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-20

Patient: female, weighing 79.4 kg (174.7 pounds)

Reactions: Sick Sinus Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: double blinded
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-24
    End date: 2012-07-11

Afinitor
    Dosage: double blinded
    Administration route: Oral

Blinded NO Treatment Received
    Dosage: double blinded
    Administration route: Oral

Blinded NO Treatment Received
    Dosage: double blinded
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-24
    End date: 2012-07-11

Carbamazepine
    Dosage: 200 mg, tid
    Indication: Convulsion
    Start date: 2001-01-01

Cymbalta
    Dosage: unk
    Indication: Depression
    Start date: 2012-02-10

Insulin
    Dosage: 20 uam 4 upm
    Indication: Diabetes Mellitus
    Start date: 2006-10-01

Levothyroxine Sodium
    Dosage: 150 mg qpm
    Indication: Hypothyroidism
    Start date: 2008-01-01

Lipitor
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Hypercholesterolaemia
    Start date: 2001-01-01

Lipitor
    Indication: Hypertriglyceridaemia

Placebo
    Dosage: double blinded
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-24
    End date: 2012-07-11

Placebo
    Dosage: double blinded
    Administration route: Oral

Trazodone Hydrochloride
    Dosage: 100 mg, qhs
    Indication: Depression
    Start date: 2008-01-01

Wellbutrin
    Dosage: 150 mg qpm
    Indication: Depression
    Start date: 2008-01-01



Possible Cymbalta side effects in male

Reported by a physician from Japan on 2012-07-19

Patient: male, weighing 67.0 kg (147.4 pounds)

Reactions: Hypoglycaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cymbalta

Other drugs received by patient: Basen; Sitagliptin Phosphate; Neurotropin / 06251301 /; Amaryl; Basen; Avapro; Sitagliptin Phosphate; Actos



Possible Cymbalta side effects in 29 year old male

Reported by a individual with unspecified qualification from United States on 2012-07-18

Patient: 29 year old male, weighing 158.8 kg (349.3 pounds)

Reactions: Grand MAL Convulsion, Serotonin Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cymbalta
    Dosage: 60mg 3 caps daily 1x daily po
    Administration route: Oral
    Indication: Depression
    Start date: 2007-01-01
    End date: 2012-06-14

Cymbalta
    Dosage: 60mg 3 caps daily 1x daily po
    Administration route: Oral
    Indication: Anxiety
    Start date: 2007-01-01
    End date: 2012-06-14



Possible Cymbalta side effects in

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient:

Reactions: Apgar Score LOW, Psychomotor Hyperactivity, Speech Disorder Developmental, Cyanosis Neonatal, Aggression, Off Label Use, Autism, Small FOR Dates Baby, Middle Insomnia, Neonatal Respiratory Depression, Developmental Delay, Hypotonia Neonatal, Mental Disorder, Disturbance in Attention, Crying

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cymbalta
    Dosage: unk
    Indication: Bipolar Disorder
    Start date: 2007-01-01
    End date: 2008-01-01

Cymbalta
    Dosage: unk
    Start date: 2007-01-01
    End date: 2008-01-01

Other drugs received by patient: Geodon; Depakote; Depakote; Prenatal Vitamins / 01549301 /; Prenatal Vitamins / 01549301 /; Geodon



Possible Cymbalta side effects in male

Reported by a consumer/non-health professional from United States on 2012-07-17

Patient: male

Reactions: Foot Fracture, Ventricular Tachycardia, Soft Tissue Inflammation, Trifascicular Block

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cymbalta
    Dosage: 60 mg, each morning
    End date: 2012-07-02

Cymbalta
    Dosage: 30 mg, each morning
    Start date: 2012-07-03

Cymbalta
    Dosage: 60 mg, qd
    Start date: 2009-01-01

Cymbalta
    Dosage: 90 mg, qd

Other drugs received by patient: Carbamazepine; Carbamazepine; Aspirin; Therapeutic-M; Doxepin; Diovan; Propecia; Keppra; Fluoxetine HCL; Keppra; Ascorbic Acid; Lipitor; Zetia



Possible Cymbalta side effects in 55 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-16

Patient: 55 year old female, weighing 93.4 kg (205.6 pounds)

Reactions: Rash, Device Failure, Foot Fracture, Oral Pain, Oral Disorder, Skin Cancer, Oedema, Oedema Mouth, Oral Mucosa Erosion

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cymbalta
    Indication: Back Pain

Cymbalta
    Indication: Major Depression



Possible Cymbalta side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-13

Patient: female, weighing 77.1 kg (169.6 pounds)

Reactions: Anxiety, Post-Traumatic Stress Disorder, Suicidal Behaviour, Condition Aggravated, Social Phobia, Depression

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cymbalta
    Dosage: 180 mg daily pills
    Indication: Social Phobia
    Start date: 2008-01-01
    End date: 2012-01-01

Cymbalta
    Dosage: 180 mg daily pills
    Indication: Post-Traumatic Stress Disorder
    Start date: 2008-01-01
    End date: 2012-01-01

Cymbalta
    Dosage: 180 mg daily pills
    Indication: Anxiety
    Start date: 2008-01-01
    End date: 2012-01-01

Cymbalta
    Dosage: 180 mg daily pills
    Indication: Depression
    Start date: 2008-01-01
    End date: 2012-01-01



Possible Cymbalta side effects in female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-07-13

Patient: female, weighing 79.4 kg (174.7 pounds)

Reactions: Sick Sinus Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Afinitor
    Dosage: double blinded
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-24
    End date: 2012-07-11

Blinded NO Treatment Received
    Dosage: double blinded
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-24
    End date: 2012-07-11

Carbamazepine
    Dosage: 200 mg, tid
    Indication: Convulsion
    Start date: 2001-01-01

Cymbalta
    Dosage: unk
    Indication: Depression
    Start date: 2012-02-10

Insulin
    Dosage: 20 uam 4 upm
    Indication: Diabetes Mellitus
    Start date: 2006-10-01

Levothyroxine Sodium
    Dosage: 150 mg qpm
    Indication: Hypothyroidism
    Start date: 2008-01-01

Lipitor
    Indication: Hypertriglyceridaemia

Lipitor
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Hypercholesterolaemia
    Start date: 2001-01-01

Placebo
    Dosage: double blinded
    Administration route: Oral
    Indication: Diffuse Large B-Cell Lymphoma
    Start date: 2011-10-24
    End date: 2012-07-11

Trazodone Hydrochloride
    Dosage: 100 mg, qhs
    Indication: Depression
    Start date: 2008-01-01

Wellbutrin
    Dosage: 150 mg qpm
    Indication: Depression
    Start date: 2008-01-01



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017